Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

HyperMed Inc
Profile last edited on: 11/19/09      CAGE: 1Y3C6      UEI:

Business Identifier: Imaging products for the diabetic and peripheral disease markets
Year Founded
1997
First Award
2004
Latest Award
2007
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

305 Second Avenue Suite B
Waltham, MA 02451
   (781) 487-0545
   N/A
   www.hypermed-inc.com
Location: Single
Congr. District: 05
County: Middlesex

Public Profile

In the Summer of 2009, HyperMed Inc has ceased operating. HyperMed is developing and commercializing medical hyperspectral imaging (MHSI) products. The Company has created the first hyperspectral imaging platform for use in medical and surgical applications. HyperMed's first product, OxyVu(TM), initially targets the screening, diagnosis, and monitoring of diabetic foot disease and peripheral arterial disease (PAD)

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
1
Conversion Rate
100.00%
Phase I Dollars
$477,728
Phase II Dollars
$2,531,543
Total Awarded
$3,009,271

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
5-9

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2007 2 NIH $3,009,271
Project Title: Hyperspectral Imaging to Predict and Assess Foot Ulcers

Key People / Management

  Anita Karcz -- President

  Jenny E Freeman

Company News

There are no news available.